Mednet Logo
SpecialtiesNeurosurgery
Neurosurgery

Neurosurgery

Physician insights on operative techniques, spinal disorders, neuro-oncology, cerebrovascular disease, and functional neurosurgery.

Recent Discussions

How do you manage TTFields for a patient with glioblastoma in the setting of disease progression?

1 Answers

Mednet Member
Mednet Member
Neurology · Wake Forest School of Medicine

Continuation of Tumor Treating Field (TTF) therapy at progression is an individualized decision for each patient.In the EF-14 trial upon which TTF was approved for newly diagnosed GBM after chemoradiotherapy, TTF was able to be continued until second progression. In this study, 18% more patients wer...

Do you discourage patients from skydiving/roller coasters with a Chiari malformation?

1 Answers

Mednet Member
Mednet Member
Neurology · Greater Boston Headache Center at Boston Advanced Medicine

No, I don't.

What workup do you recommend for patients with low back pain and imaging concerning for spina bifida occulta?

1 Answers

Mednet Member
Mednet Member
Neurology · Hospital for Special Surgery

In cases of suspected spina bifida occulta, imaging of the entire spine and Neurosurgery referral are usually recommended. MRI is generally considered the imaging modality of choice, which can also detect other coexisting abnormalities such as tethered cord, while CT can be helpful in better imaging...

When would you recommend standard of care over hypofractionated treatment in an elderly patient diagnosed with Glioblastoma?

1 Answers

Mednet Member
Mednet Member
Neurology · Wake Forest School of Medicine

Treatment of patients with newly diagnosed GBM who are >70 years of age is controversial and treatment decisions should be individualized. Some patients who are GREATER THAN 70 years of age are candidates for standard 6-week RT+TMZ and some patients who are LESS THAN 70 years of age may require modi...

How do you discuss curative vs palliative treatment intent for patients with favorable risk 1p/19q co-deleted oligodendrogliomas?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Montreal

Although my name is on a publication calling low-grade oligodendroglioma an "incurable disease", this is not a term that I use with patients — even in the case of glioblastoma. We do not have a published 20-year follow-up of RTOG 9802 to see if there is a plateau in PFS. Are we only delaying inevita...

Would you recommend upfront radiosurgery for trigeminal neuralgia caused by AVM abutment at the entry root zone?

3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Florida International University

Radiosurgery (SRS) at high doses to the dorsal nerve root entry zone is an effective treatment modality for primary or idiopathic trigeminal neuralgia (TN), but is significantly less efficacious when utilized for secondary trigeminal neuralgia, as caused by tumors, plaques, AVMs, etc. There are case...

What is the role of kyphoplasty or vertebroplasty in patients with osteoporotic spinal fractures?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · U of AZ Phoenix Dept of Orthopaedics

Vertebroplasty and kyphoplasty can be grouped together as vertebral augmentation. They have a single indication: To reduce pain arising from a documented vertebral fracture. Kyphoplasty has an inflatable balloon and in theory, can improve vertebral height prior to introduction of the cement. I am no...

How would you manage a recurrent anaplastic supratentorial ependymoma in an adult?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Florida International University

There is no well-defined standard-of-care approach for previously irradiated, now recurrent ependymoma, in any setting, whether it is adult or pediatric, cranial or spinal, and supra vs. infratentorial. Unfortunately, the natural history at this stage is characterized by multiple relapses, each with...

What would your next line treatment be for a patient previously treated with repeat resection, craniospinal irradiation, and initial cisplatin/vincristine/CCNU with medulloblastoma?

1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · C. S. Mott Children’s Hospital, University of Michigan

As you will agree, this is an extremely unfortunate situation. I am assuming this patient has progressed either while on therapy or soon after completion? Depending on his age, a potential option is to enroll him on any available clinical trials. PBTC58 study uses intrathecal omburtumab along with c...

How do you approach treatment of a grade 4 IDH-mutant astrocytoma, a diagnosis now distinct from glioblastoma according to the 2021 WHO Classification for CNS Tumors?

2
1 Answers

Mednet Member
Mednet Member
Medical Oncology · Nebraska Medcal Center

This is an excellent question. The short answer is that until we have more data on this new entity, I would treat an IDH mutant (mt) grade 4 astrocytoma as I would have prior to the 2021 WHO revision, that is to say, with concurrent chemoradiation therapy and adjuvant Temodar for 6 cycles (or a clin...